Cryptosporidiosis after CD34-selected autologous peripheral blood stem cell transplantation (PBSCT). Treatment with paromomycin, azithromycin and recombinant human interleukin-2

Bone Marrow Transplantation

Volumn 19, Issue 12, 1997, Pages 1261-1263

  Nachbaur, D ^a   Kropshofer, G ^a   Feichtinger, H ^a   Allerberger, F ^a   Niederwieser, D ^a  

^a UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

Author keywords

CD34 selection; Cryptosporidiosis; Immune reconstitution; PBSCT; rhIL 2

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; CD34 ANTIGEN; PAROMOMYCIN; RECOMBINANT INTERLEUKIN 2;

ADULT; ARTICLE; CASE REPORT; CRYPTOSPORIDIOSIS; FEMALE; HUMAN; IMMUNE SYSTEM; LYMPHOCYTE COUNT; LYMPHOMA; MALE; OPPORTUNISTIC INFECTION; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; SUBCUTANEOUS DRUG ADMINISTRATION; T LYMPHOCYTE;

EID: 0030809038     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1700826     Document Type: Article

References (24)

1. Brunvand MW, Bensinger WI, Soll E et al. High-dose fractionated total-body irradiation, etoposide and cyclophosphamide for treatment of malignant lymphoma: comparison of autologous bone marrow and peripheral blood stem cells. Bone Marrow Transplant 1996; 18: 131-141.
2. Brenner MK, Rill DR, Moen RC et al. Gene-marking to trace origin of relapse after autologous bone-marrow transplantation. Lancet 1993; 341: 85-86.
3. + cells to remove circulating tumor cells. Blood 1996; 87: 1625-1634.
4. + peripheral blood progenitor cells after high-dose chemotherapy for patients with advanced multiple myeloma. Blood 1995; 86: 390-397.
5. Petersen C. Cryptosporidiosis in patients infected with the human immunodeficiency virus. Clin Infect Dis 1992; 15: 903-909.
6. Collier AC, Miller RA, Meyers JD. Cryptosporidiosis after marrow transplantation. Person-to-person transmission and treatment with spiramycin. Ann Intern Med 1984; 101: 203-204.
7. Gentile G, Venditti M, Micozzi A et al. Cryptosporidiosis in patients with hematalogic malignancies. Rev Infect Dis 1991; 13: 842-846.
8. Martino P, Gentile G, Caprioli A et al. Hospital-acquired cryptosporidiosis in a bone marrow transplantation unit. J Infect Dis 1988; 158: 842-846.
9. Khaw M, Panosian CB. Human antiprotozoal therapy: past, present and future. Clin Microbiol Rev 1995; 8: 427-439.
10. Symann M, Bosly A, Gisselbrecht C et al. Immune reconstitution after bone marrow transplantation. Cancer Treat Rev 1989; 6 (Suppl. A): 15-19.
11. Ashihara E, Shimazaki C, Yamagata N et al. Reconstitution of lymphocyte subsets after peripheral blood stem cell transplantation: two-color flow cytometric analysis. Bone Marrow Transplant 1994; 13: 377-381.
12. Roberts MM, To LB, Gillis D et al. Immune reconstitution following peripheral blood stem cell transplantation, autologous bone marrow transplantation and allogeneic bone marrow transplantation. Bone Marrow Transplant 1993; 12: 469-475.
13. Talmadge JE, Reed E, Ino K et al. Rapid immunologic reconstitution following transplantation with mobilized peripheral blood stem cells as compared to bone marrow. Bone Marrow Transplant 1997; 19: 161-172.
14. + hematopoietic progenitors for autologous marrow transplantation after high dose chemotherapy. In: Dicke KA, Keating A (eds). Autologous Marrow and Blood Transplantation, Proceedings of the Seventh International Symposium. Arlington, Texas, August 17-20, 1994, pp 669-675.
15. Brugger SA, Kahls P, Keil F et al. Haematological and immunological reconstitution after high dose radio and/or chemotherapy with supportive infusion of unselected and CD34+-enriched peripheral stem cells. Ann Hematol 1996; 73 (Suppl. 2): 165 (Abstr. 657).
16. Finke J, Behringer D, Bertz H et al. Allogeneic peripheral blood stem cell transplantation with or without CD34+ selection: rapid immune reconstitution and low incidence of GVHD. Ann Hematol 1996; 73 (Suppl. 2): 165 (Abstr. 658).
17. + blood cells. Blood 1996; 87: 4903-4909.
18. Keever CA, Small TN, Flomenberg N et al. Immune reconstitution following bone marrow transplantation: comparison of recipients of T cell depleted marrow with recipients of conventional marrow grafts. Blood 1989; 73: 1340-1350.
19. Pirsch JD, Maki DG. Infectious complication in adults with bone marrow transplantation and T-cell depletion of donor marrow. Increased susceptibility to fungal infections. Ann Intern Med 1986; 104: 619-631.
20. Weaver CH, Hazelton B, Birch R et al. An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy. Blood 1995; 86: 3961-3969.
21. Bensinger W, Appelbaum, Rowley S et al. Factors that influence collection and engraftment of autologous peripheral-blood stem cells. J Clin Oncol 1995; 13: 2547-2555.
22. López-Vélez R. Tarazona R et al. Intestinal and extraintestinal cryptosporidiosis in AIDS patients. Eur J Clin Microbiol Infect Dis 1995; 14: 677-681.
23. Klingemann H-G. Trying to overcome residual disease after bone marrow transplantation for hematologic malignancies. Leuk Lymphoma 1992; 8: 421-429.
24. Lauria F, Raspadori D, Ventura MA et al. Immunologic and clinical modifications following low-dose subcutaneous administration of rIL-2 in non-Hodgkin's lymphoma patients after autologous bone marrow transplantation. Bone Marrow Transplant 1996; 18: 79-85.